Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00225615
Status:
COMPLETED
Last Update Posted:
2009-08-20
First Post:
2005-09-22
Brief Title:
A Phase 3 Multicenter Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Organization Data
Organization:
BioMarin Pharmaceutical
Class:
INDUSTRY
Study ID:
PKU-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioMarin Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None